Drug
Blu 924
Blu 924: highest development phase Phase 1/2, developed by Blueprint Medicines. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Blueprint Medicines
Trials
| Drug | Phase | Indication |
|---|---|---|
| BLU-924 NCT07629960 | Phase 1/2 | Advanced Solid Tumor |
Latest
No recent events.
Follow Blu 924 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.